Because melastatin, a MITF transcriptional target and a putative tumour suppressor, is sharply responding to MITF levels in melanocytes 36, we used real‐time PCR to estimate the mRNA levels of melastatin, together with determining the mRNA levels of the bona fide MITF target tyrosinase. Here, MITF is linked to neoplasm.